Name: Latest research reports of Ipca Laboratories Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Ipca Laboratories Ltd.
Rating: 5
Author: Motilal Oswal

Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Mid-range Performer

1488.3000 -19.90 (-1.32%)

NSE Apr 02, 2026 15:31 PM

27.40% Gain from 52W Low

Volume: 196.4K

Ipca Laboratories Ltd.

14 Oct 2024

1488.30

-1.32%

At an inflexion point

Buy: Ipca Laboratories Ltd.

Recommendation Target

Motilal Oswal

After three years of earnings deterioration, IPCA is well-poised to deliver strong earnings growth over FY24-27.

Ipca Laboratories Ltd. has an average target of 1806.67 from 3 brokers.